Table 14.
n | Method |
TRLSa |
TRRLSa |
TARLSa |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | RN | RR | Mean | SD | RN | RR | ||
100 | ML | 308.96 | 86.38 | 84.39 | 18.34 | 31 | 11.1% | 28.25 | 5.96 | 7 | 2.5% |
ML.1 | 195.18 | 32.15 | 87.73 | 14.43 | 68 | 7.4% | 32.43 | 5.48 | 10 | 1.1% | |
ML.2 | 137.51 | 22.78 | 89.39 | 14.86 | 96 | 9.6% | 34.68 | 5.65 | 14 | 1.4% | |
200 | ML | 308.33 | 56.25 | 86.88 | 15.26 | 73 | 7.7% | 39.84 | 7.45 | 15 | 1.6% |
ML.1 | 194.32 | 33.32 | 88.33 | 15.15 | 92 | 9.2% | 44.80 | 7.54 | 33 | 3.3% | |
ML.2 | 135.86 | 22.43 | 88.40 | 14.70 | 85 | 8.5% | 47.00 | 7.56 | 25 | 2.5% | |
300 | ML | 308.44 | 60.13 | 88.09 | 16.58 | 103 | 10.3% | 46.20 | 8.85 | 46 | 4.6% |
ML.1 | 193.14 | 34.29 | 88.11 | 15.57 | 86 | 8.6% | 50.98 | 8.85 | 40 | 4.0% | |
ML.2 | 135.47 | 23.21 | 88.10 | 15.10 | 83 | 8.3% | 53.38 | 8.89 | 38 | 3.8% | |
400 | ML | 305.32 | 54.38 | 87.95 | 15.30 | 87 | 8.7% | 49.68 | 8.72 | 37 | 3.7% |
ML.1 | 192.26 | 31.58 | 87.91 | 14.49 | 74 | 7.4% | 54.65 | 8.85 | 37 | 3.7% | |
ML.2 | 135.11 | 21.58 | 87.90 | 14.14 | 72 | 7.2% | 57.22 | 8.97 | 35 | 3.5% |